Webinar :Don't miss the exciting session on 'Make in India: Pharmacy of the World' where top business leaders reveal how the life sciences and pharma sector can become more aatmanirbhar. Click to attend:
you are here: HomeNewsBusiness

Buy Jyothy Laboratories; target of Rs 188: Sharekhan

Sharekhan is bullish on Jyothy Laboratories has recommended buy rating on the stock with a target price of Rs 188 in its research report dated January 27, 2021.

January 29, 2021 / 07:13 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Sharekhan's research report on Jyothy Laboratories


Q3FY21 was yet another strong quarter for Jyothy Labs (JLL) with consolidated revenues growing by 13.3%yoy to Rs. 476.6 crore (led by a 15% volume growth) and OPM expanding by 100 bps to 16.8%; PAT growth stood at 18.5%. Personal care and dishwashing products clocked strong growth of 48% and 21% respectively, driving Q3 performance house hold insecticide (HI) segment too grew by ~10%. Higher demand for dishwashing and personal care products and expected improvement in growth of fabric care segment will help JLL post double-digit growth in coming quarters. OPM to sustain at 16-17% in the near to medium term..


Outlook


We raise our earnings estimates for FY2022/23 by 7-9% to factor in better-than-expected growth in personal care products and expected recovery in fabric care category. Stock trades at discounted valuation of 18.6x its FY2023E EPS; maintain Buy with revised PT of Rs. 188.


For all recommendations report, click here


Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Broker Research
first published: Jan 29, 2021 07:13 pm

stay updated

Get Daily News on your Browser
Sections